Walleye Trading’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,473
Closed -$115K 4747
2023
Q4
$191K Buy
+20,473
New +$141K ﹤0.01% 3811
2022
Q3
Sell
-28,680
Closed -$287K 5024
2022
Q2
$287K Buy
+28,680
New +$272K ﹤0.01% 3415
2021
Q4
Sell
-142
Closed -$3K 5343
2021
Q3
$3K Sell
142
-60,999
-100% -$1.21M ﹤0.01% 5094
2021
Q2
$1.4M Buy
+61,141
New +$906K 0.01% 1832

Other funds holding AVXL

Walleye Trading's AVXL Position: Q1 2024 in Review

Walleye Trading sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 20,473 shares — an estimated $115K sold.

Walleye Trading first reported a position in AVXL in Q2 2021 and held it in 4 quarters. The position peaked at $1.4M in Q2 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

  • Walleye Trading reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 20,473 Anavex Life Sciences shares in Q1 2024, an estimated $115K.
  • Walleye Trading first reported a position in Anavex Life Sciences in Q2 2021 and held it in 4 quarters.
  • Walleye Trading's Anavex Life Sciences position peaked at $1.4M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.